Quantcast

Biden Wants Billions More For Vaccines

WASHINGTON (AP) — The Biden administration is making billions of dollars available to drugmakers to scale up domestic production of COVID-19 vaccines in the hopes of building capacity to produce an additional 1 billion shots per year to share with the world.

Under the new initiative, the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority is soliciting pharmaceutical companies that have demonstrated the ability to make the more-effective mRNA vaccines to bid for government investment in scaling up their manufacturing abilities.

Drugmakers Pfizer and Moderna produce the two U.S.-approved mRNA shots.

The Biden administration believes the boosted capacity of COVID-19 shots will help ease a global shortage of doses, particularly in lower- and middle-income nations, stopping preventable death and limiting the development of potentially new, more dangerous variants of the virus.

Given that pharmaceutical industry revenues worldwide topped 1.25 trillion U.S. dollars in 2020, should taxpayers be expected to fund expansion of vaccine capacity? Comment below. 

...article continued below
- Advertisement -

The initiative comes as the Biden White House has faced growing pressure at home and abroad over inequity in the global vaccine supply — as the U.S. moves toward approving booster shots for all adults while vulnerable people in poorer nations wait for their first dose of protection.

There are no firm agreements yet with Moderna or Pfizer to take up the U.S. on the investment.

Still, the Biden administration hopes that the enhanced manufacturing capacity, through support for the company’s facilities, equipment, staff or training, will be available by mid-2022 to allow more COVID-19 doses to be shared overseas as well as to prepare for the next public health emergency.

The announcement was previewed Wednesday by an administration official who spoke on the condition of anonymity to discuss the matter before the official release.

The New York Times first reported on the new initiative.

...article continued below
- Advertisement -

Given that pharmaceutical industry revenues worldwide topped 1.25 trillion U.S. dollars in 2020, should taxpayers be expected to fund expansion of vaccine capacity? Comment below. 

- Advertisement -

TRENDING

US Food Industry Poisons Consumers: Consumer Advocate

FOOD SAFETY NEWS – Some, I am sure, are a bit tired of my ranting about the FSIS doing its job and deeming Salmonella...

Judge Halts Federal Vaccine Mandate For Health Workers In Ten States

NEW HAMPSHIRE UNION-LEADER – A federal judge blocked the government on Monday from mandating COVID-19 vaccinations for health care workers in New Hampshire and...

Deadly Flu Season Forecast For Older Americans

WTOP – The flu season is beginning to gain traction with a predominant strain that concerns one infectious disease expert, and he’s urging everyone 6...

‘Vaccine Inequity’ Seen As Omicron Incubator

The emergence of the new omicron variant and the world's desperate and likely futile attempts to keep it at bay are reminders of what scientists have warned for months: The coronavirus will thrive as long as vast parts of the world lack vaccines.

Couple Pulled Off Plane After Fleeing Quarantine

Dutch authorities have isolated 61 people who tested positive for COVID-19 on two arriving flights originating from South Africa, Saturday, Nov. 27, 2021. Authorities are carrying out further investigations to see if any of the travelers have the omicron variant.

‘All-Or-Nothing’ Abortion Case Reaches Supreme Court

Both sides are telling the Supreme Court there’s no middle ground in Wednesday’s showdown over abortion. The justices can either reaffirm the constitutional right to an abortion or wipe it away altogether.

Omicron Finger-Pointing Begins

Many of the world's richest countries have spent the past year hoarding coronavirus vaccines, buying up enough doses to vaccinate their populations several times over and consistently failing to deliver on their promises to share doses with the developing world. The World Health Organization said the approach was "self-defeating" and "immoral."

Governors Urge Caution On Omicron

Governors across the United States tried to reassure Americans on Sunday that their administrations were closely monitoring the impact of a new coronavirus variant that has alarmed scientists.

FDA: Merck COVID Pill Effective, Safety Questions Remain

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy.

Ivermectin, ‘Miracle Drug’?

MedPage Today – Pierre Kory, MD, one of the most vocal proponents of ivermectin, got COVID-19 in August, despite taking the anti-parasitic medication on...
- Advertisement -